Re: AVX - Avexa Limited
gee, well the market hasnt liked this proposal im not sure if i do either. it seems the only thing progen have to offer is their cash like you said wilsta.
so if this goes ahead like planned and say the share buy back is fully utilised by progen shareholders, we have a combined entity with about 65-75m shares on issue. (progens current 48m less share buy back of 18m=30m)(plus 450m avx shares /12.857 = 35m)
and considering the combined entity will have cash reserves of about 60m, does this mean we are getting avx phase 111 ATC drug for free?? which seems quite absurd.although it is unclear as to the amount of revenue ATC could potentially generate if any?? some analysts have placed 400m on it. which suggests avx is highly undervalued?? using a 10% discount rate i came up with a price of $4 for the combined entity,which equates to about 55c for AVX if the merger never occured.These obviously long term targets(2012+).
i would like to see if anyone else has come up with their own value of avexa.
gee, well the market hasnt liked this proposal im not sure if i do either. it seems the only thing progen have to offer is their cash like you said wilsta.
so if this goes ahead like planned and say the share buy back is fully utilised by progen shareholders, we have a combined entity with about 65-75m shares on issue. (progens current 48m less share buy back of 18m=30m)(plus 450m avx shares /12.857 = 35m)
and considering the combined entity will have cash reserves of about 60m, does this mean we are getting avx phase 111 ATC drug for free?? which seems quite absurd.although it is unclear as to the amount of revenue ATC could potentially generate if any?? some analysts have placed 400m on it. which suggests avx is highly undervalued?? using a 10% discount rate i came up with a price of $4 for the combined entity,which equates to about 55c for AVX if the merger never occured.These obviously long term targets(2012+).
i would like to see if anyone else has come up with their own value of avexa.